Literature DB >> 11190918

[Economic limits in intensive care. Can we still afford intensive care in the year 2000?].

D Barckow1.   

Abstract

Intensive care medicine currently accounts for about 20% of the overall budget of a hospital. A certain reduction of these expenses may be reached through a rationalisation of medical care procedures and structures. The evaluation of procedure efficacy and outcomes, however, is mandatory for the quality assurance of treatment results. A possible rationing of intensive care therapy is difficult to imagine since the current practice of intensive care medicine is also based on humanitarian grounds. The associated costs have to be born by society as a whole. Intensive care medicine though, has to continuously reevaluate and discuss its goals with society.

Mesh:

Year:  2000        PMID: 11190918

Source DB:  PubMed          Journal:  Z Arztl Fortbild Qualitatssich        ISSN: 1431-7621


  2 in total

Review 1.  [Necessity and problems with case-related costing for intensive care patients].

Authors:  M Weiss; J Martin; U Feser; C Schafmayer; M Bauer
Journal:  Anaesthesist       Date:  2005-03       Impact factor: 1.041

2.  Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version.

Authors:  Jörg Martin; Anja Heymann; Katrin Bäsell; Ralf Baron; Rolf Biniek; Hartmut Bürkle; Peter Dall; Christine Dictus; Verena Eggers; Ingolf Eichler; Lothar Engelmann; Lars Garten; Wolfgang Hartl; Ulrike Haase; Ralf Huth; Paul Kessler; Stefan Kleinschmidt; Wolfgang Koppert; Franz-Josef Kretz; Heinz Laubenthal; Guenter Marggraf; Andreas Meiser; Edmund Neugebauer; Ulrike Neuhaus; Christian Putensen; Michael Quintel; Alexander Reske; Bernard Roth; Jens Scholz; Stefan Schröder; Dierk Schreiter; Jürgen Schüttler; Gerhard Schwarzmann; Robert Stingele; Peter Tonner; Philip Tränkle; Rolf Detlef Treede; Tomislav Trupkovic; Michael Tryba; Frank Wappler; Christian Waydhas; Claudia Spies
Journal:  Ger Med Sci       Date:  2010-02-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.